Jenscare Scientific Co., Ltd. (HKG:9877)

Market Cap	2.63B -39.2%
Revenue (ttm)	163.12M +952.4%
Net Income	-173.58M
EPS	-0.40
Shares Out	417.10M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,800
Open	6.32
Previous Close	6.17
Day's Range	6.30 - 6.32
52-Week Range	5.79 - 10.52
Beta	0.63
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About Jenscare Scientific

Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of interventional products for the treatment of structural heart diseases in the People’s Republic of China. It offers LuX-Valve and LuX-Valve Plus, a transcatheter tricuspid valve replacement (TTVR) product for the treatment of severe tricuspid regurgitation and high surgical risk; Ken-Valve, a TRVR system for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops JensClip, a clip-based transcathete...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 225
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9877

Financial Performance

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error